Virtual reality technology for pain management in advanced cancer
- PMID: 39560064
- PMCID: PMC11574948
- DOI: 10.1002/14651858.CD016078
Virtual reality technology for pain management in advanced cancer
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primarily, to determine the effectiveness of a virtual reality (VR) intervention compared to an alternative or no intervention for people living with advanced cancer: on pain intensity, adverse events (AEs) and serious adverse events (SAEs); and secondarily, on additional pain properties (e.g. type, frequency), psychological well-being, other physical symptoms (e.g. anxiety) and quality of life. We will also report on the context in which the VR was implemented (setting, type and dose of VR).
Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Conflict of interest statement
NW, OM, BH, VV, PW: no commercial or non‐commercial conflicts of interest relevant to this review.
MT: is a shareholder in a virtual reality enterprise, and no non‐commercial conflicts of interest relevant to this review.
KF: is completing a ESRC PhD studentship, co‐funded by Rescape Innovation Ltd (purveyor of a VR platform). Rescape Innovation Ltd are not involved in any aspect of this review.
References
-
- Macmillan Cancer Support. Treatable but not curable cancer. https://www.macmillan.org.uk/treatable-but-not-curable-cancer (accessed 22 October 2024).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical